ProBio · 2 hours ago
Talent Acquisition Partner, Intern
GenScript Biotech Corporation is a global biotechnology group committed to improving health through biotechnology. ProBio is seeking a Talent Acquisition Intern to conduct high-volume recruitment activities, assist in employer branding, and support various HR functions.
BiopharmaBiotechnologyLife ScienceMedicalPharmaceutical
Responsibilities
Conduct full-cycle recruitment activities to ensure successful Talent Acquisition from a technical and cultural perspective for open positions in US sites
Assist in the efforts of employer branding on social media and other channels
Develop recruiting channels to effectively perform searches for qualified candidates
Select qualified job applicants and make hiring recommendations when appropriate
Analyze employment-related data and prepare required reports
Conduct background and reference checks, along with e-Verify process
Conduct new employee orientation and interpret human resources policies, procedures, laws, standards, or regulations
Maintain current knowledge of Equal Employment Opportunity (EEO) and affirmative action guidelines and laws, such as the Americans with Disabilities Act (ADA)
Provide as needed support for continuous improvement projects, onboarding of employees and implementation of new HR services
Responsible for other duties as assigned
Qualification
Required
Current undergraduate or graduate student majoring in Human Resources, Business Administration, Psychology, Communications, or a related field
Strong interest in HR, recruiting, or talent management
Excellent communication and interpersonal skills
Highly organized, proactive, and detail-oriented
Ability to manage multiple tasks in a fast-paced environment
Proficiency in Microsoft Office
Preferred
Experience with ATS systems is a plus
Company
ProBio
ProBio is a global contract development and manufacturing (CDMO) organization, which aims to accelerate the manufacturing of life-changing drugs, discover novel therapeutic targets, and develop innovative therapeutic approaches to manufacture best-in-class DNA, RNA, and protein-based therapeutics.
Funding
Current Stage
Growth StageTotal Funding
$220MKey Investors
Legend Capital
2023-01-18Series C· $220M
Leadership Team
Recent News
Company data provided by crunchbase